NOVERIS HEALTH SCIENCES (MYCOF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 42 55 sessions, August 4, 2025 to August 4, 2026
- Largest daily move
- +2600% close of September 22, 2025
- 1-year change
- +131.7% closing prices, August 4, 2025 to August 4, 2026
- 1-month change
- -63.5% closing prices, June 23, 2026 to August 4, 2026
Company Description
NOVERIS HEALTH SCIENCES (OTC: MYCOF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $42.7M.
MYCOF has gained 131.7% over the past year. The last closing price was $0.7300.
This page collects what Stock Titan holds for MYCOF, including price data, latest news, upcoming events, and short interest trends.
Stock Performance
NOVERIS HEALTH SCIENCES (MYCOF) closed at $0.7300 on August 4, 2026. Over the past 12 months, the price has gained 131.7%.
MYCOF Metrics & Rankings
Price returns through August 4, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
NOVERIS HEALTH SCIENCES has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 4 with negative movement. Key topics include private placement, earnings. View all MYCOF news →
SEC Filings
Financial Highlights
Upcoming Events
Conversion eligibility
Hold period expiry
Debenture maturity
Warrant expiry
NOVERIS HEALTH SCIENCES has 4 upcoming scheduled events. The next event, "Conversion eligibility", is scheduled for December 28, 2026 (in 70 days). 3 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the MYCOF stock price.
Short Interest History
Short interest in NOVERIS HEALTH SCIENCES (MYCOF) currently stands at 637 shares, representing 0.0% of the float.
Days to Cover History
Days to cover for NOVERIS HEALTH SCIENCES (MYCOF) currently stands at 1000.0 days, up 99899% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since March 2026, the figure has increased by 99899%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
MYCOF Company Profile & Sector Positioning
NOVERIS HEALTH SCIENCES (MYCOF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing MYCOF often look at related companies in the same sector, including CANAQUEST MED CORP (CANQF), REAL BRANDS INC (RLBD), INDOOR HARVEST CORP (INQD), BRANDED LEGACY INC (BLEG), and LOWELL FARMS INC (LOWLF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MYCOF's relative position within its industry.